[1]
Lertsirimunkong, J., Thavornwattanayong, W., Pradab, J., Khongbun, J., Khunphong, K. and Panyasrilert, N. 2026. Cost-Effectiveness Analysis of Rimegepant Versus Eletriptan for Patients with Acute Episodic Migraine in Thailand: Establishing Dominance from a Societal Perspective. Siriraj Medical Journal. 78, 9 (Sep. 2026), 660–670. DOI:https://doi.org/10.33192/smj.v78i9.282940.